MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
Sort
Language
Type
Field
Venue
Annals of the Rheumatic Diseases
Topic
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

2,612 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
2,612 works in the cohort · of 4,299,418page 1 of 53

Labels cover 7 of 2,612 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 2,612 of 2,612 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

affno abstractunlabeled
Long-term patient survival in ANCA-associated vasculitis
Oliver Floßmann, Annelies E. Berden, Kirsten de Groot, Chris Hagen, Lorraine Harper, Caroline Heijl +10 more
2010· article· en· Annals of the Rheumatic Diseases· Medicine
machine prediction:candidate · noneconsensus · none
930
citations
affunlabeled
Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate
George A. Wells, J-C Becker, J. Teng, Maxime Dougados, Michael Schiff, Josef S Smolen +2 more
2008· article· en· Annals of the Rheumatic Diseases· Medicine
machine prediction:candidate · noneconsensus · none
892
citations
affno abstractunlabeled
The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis
C. Roubille, Vincent Richer, Tara Starnino, Collette McCourt, Alexandra McFarlane, Patrick Fleming +10 more
2015· review· en· Annals of the Rheumatic Diseases· Medicine
machine prediction:candidate · noneconsensus · none
890
citations
affunlabeled
Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy: 6-month and 1-year results of the phase 3, multicentre, double-blind, placebo-controlled, randomised PSUMMIT 2 trial
Christopher T. Ritchlin, Proton Rahman, Arthur Kavanaugh, Iain B. McInnes, L. Puig, Shu Li +5 more
2014· article· en· Annals of the Rheumatic Diseases· Medicine
machine prediction:candidate · noneconsensus · none
658
citations
affunlabeled
Ixekizumab, an interleukin-17A specific monoclonal antibody, for the treatment of biologic-naive patients with active psoriatic arthritis: results from the 24-week randomised, double-blind, placebo-controlled and active (adalimumab)-controlled period of the phase III trial SPIRIT-P1
Philip J. Mease, Désirée van der Heijde, Masato Okada, Raquel Cuchacovich, Catherine L Shuler, Chen‐Yen Lin +3 more
2016· article· en· Annals of the Rheumatic Diseases· Medicine
machine prediction:candidate · noneconsensus · none
568
citations
affunlabeled
Treatment recommendations for psoriatic arthritis
Christopher T. Ritchlin, Arthur Kavanaugh, Dafna D. Gladman, Philip J. Mease, Philip Helliwell, Kurt de Vlam +8 more
2008· review· en· Annals of the Rheumatic Diseases· Medicine
machine prediction:candidate · noneconsensus · none
561
citations
affunlabeled
Classification criteria for autoinflammatory recurrent fevers
Marco Gattorno, Michaël Hofer, Silvia Federici, Federica Vanoni, Francesca Bovis, Ivona Aksentijevich +37 more
2019· review· en· Annals of the Rheumatic Diseases· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
561
citations
affunlabeled
EULAR definition of difficult-to-treat rheumatoid arthritis
György Nagy, Nadia M T Roodenrijs, Paco M J Welsing, Melinda Kedves, Attila Hamar, Marlies C. van der Goes +25 more
2020· article· en· Annals of the Rheumatic Diseases· Medicine
machine prediction:candidate · noneconsensus · none
539
citations

How this was built: Screen · Findings · About